SOURCE: Southern California Investment Association

Southern California Investment Association

November 24, 2009 09:30 ET

SCIA "Saturday Winter Conference"

SAN CLEMENTE, CA--(Marketwire - November 24, 2009) - Southern California Investment Association, Inc. has an exciting "Winter Conference" welcoming Brokers, Institutions, Funds and Accredited Investors looking for new opportunities Saturday, Dec. 5th, 2009 from 8:00 a.m. registration including buffet breakfast, and sit down lunch at the Hilton Hotel/Orange County Airport (949-833-3331), 18800 MacArthur Blvd., Irvine, CA 92612, conveniently located across from the John Wayne Airport (SNA).


Exciting overlooked and under-valued public and private companies are presenting new opportunities every 15 minutes after breakfast.

A Summary of Companies Presenting Saturday:

(Subject to change and additions)

BioCurex -- (OTCBB: BOCX) -- -- We are focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. We have developed and evaluated in clinical trials a blood test that can detect the presence of cancer in humans and animals using a new cancer marker named RECAF. We developed and own, royalty-free, the proprietary technology related to the RECAF marker, with patents granted in the United States, Europe and China and patents pending in other major worldwide markets.

Chestnut Energy Partners, Inc. -- (Private) -- -- The Chestnut Group of Companies is a Texas based group of energy companies that was founded by Mark A. Plummer. Mr. Plummer founded the first Chestnut Company, our independent oil and natural gas company, Chestnut Petroleum in 1994. Mr. Plummer is a licensed engineer with the state of Texas with over 26 years of oil and natural gas production enhancement and exploration experience. Our oil and natural gas production funds are designed to take advantage of the volatility in commodity prices. For these funds, we specialize in the acquisition of income producing properties, which provide investors opportunities for cash flow, potential capital appreciation, and tax benefits. Our team of in-house experts in engineering and geology possess an in-depth knowledge of the oil and natural gas industry. This knowledge allows us to develop and manage a project enhancement plan intended to maximize results as measured by investor capital appreciation, and total return. We strive to provide our investors with the highest quality income producing assets. Our expertise and experience give us the tools to buy smart, manage costs, improve production, and sell timely.

RAN Science & Technology, LLC -- (Private) -- -- Our Independent scientists will determine your concept's scientific potential, and present a factual, understandable analysis. Turn the odds in your favor. Run it by RAN.

Provectus Pharmaceuticals, Inc. -- (OTCBB: PVCT) -- -- Provectus Pharmaceuticals is a development stage company that specializes in oncology and dermatology therapies that are safer, more effective, less invasive and more economical than conventional therapies. Provectus is currently conducting Phase 2 clinical trials of their proprietary drugs PV-10 as a therapy for metastatic melanoma and PH-10 as a topical treatment for psoriasis and atopic dermatitis. Information about these and the Company's other clinical trials can be found at the NIH registry,

Micro Imaging Technology -- (OTCBB: MMTC) -- -- Micro Imaging Technology is a California public company that has developed and patented a rapid microbial identification system that can revolutionize the microbial identification (ID) industry -- by annually saving thousands of lives and millions of dollars. The MIT System performs bacteria IDs in minutes, not days, and at significant cost savings when compared to other methods -- less than 10 minutes for a cost of about $.10/test versus competitive units that take hours and days at a cost of ~$6/test. In addition, the capital cost versus other rapid ID devices is typically 30% less than others. The System uses no additives, reagents or other chemicals making it a totally GREEN system. Revenues for rapid testing methods exceed $5 billion each year in the areas of food protection and clinical diagnostic. Market expansion has been at an average rate of 10.2 percent annually since 2003 and is expected to exceed $6.2B by 2013. Recent increases in food contamination and human bacterial infection events suggest that the growth projection will increase. The System has been rigorously tested and is now certified as rapid ID test method for food contamination. Limited production has started that will be accelerated with additional financing.

About Southern California Investment Association:

SCIA National Small Cap Syndicate is a comprehensive national organization developed to facilitate stock support and capital formation for small and emerging-growth companies. The alliance consists of almost 200 influential member firms plus associates including FINRA broker/dealers, bankers, investment advisors, analysts, market makers, venture capitalists, fund managers, media and accredited investors. The syndicate provides equity and debt financing, institutional and retail stock support, market making, mergers and more. The SCIA syndicate has been instrumental in funding over $100 million per year since 2000 and has introduced many of the good companies available in the markets.

2010 Conference Schedule: Saturdays, Feb. 6th, April 3rd, June 5th, August 7th, October 2nd, and Dec. 4th.

SCIA Gold Sponsors:

Continental Stock Transfer & Trust Co.,, PCMC,

SCIA Associate Sponsors:

Marketwire,, SNN,, AlphaTrade,

Come join us for an exciting Winter Conference.

Please pre-register your attendance, and renew your membership on our web site at, and mark your meal selection also.

Thank you for your support.

Looking forward to seeing everyone on Saturday!

Contact Information